Neuropsychiatric profile of children, adolescents and young adults with tuberous sclerosis complex

Authors

  • Mariana Richartz Schwind Universidade Federal do Paraná
  • Laís Faria Masulk Cardozo Universidade Federal do Paraná
  • Sergio Antonio Antoniuk Universidade Federal do Paraná
  • Ana Paula Almeida de Pereira Universidade Federal do Paraná
  • Daniele Fajardo Nascimento Universidade Federal do Paraná
  • Daiane Alex Seccon Azevedo Universidade Federal do Paraná
  • Nayana Miranda de Freitas Falcão Universidade Federal do Paraná
  • Isac Bruck Universidade Federal do Paraná

DOI:

https://doi.org/10.18316/sdh.v5i2.3088

Keywords:

Tuberous Sclerosis, Neurologic Examination, Mental Health, Cognition

Abstract

Aim: to assess neuropsychiatric disorders and factors related to the intellectual level of patients with Tuberous sclerosis complex (TSC).

Method: a cross-sectional study with 20 patients diagnosed with TSC, recruited in a pediatric neurology center, was conducted. Participants were assessed by semi-structured interviews, medical chart information, the Wechsler Intelligence Scale, the Childhood Autism Rating Scale and the Child Behavior Checklist /Adult Self Report. A descriptive analysis of data was performed for each variable. The Comparison between groups with and without intellectual disability was performed using Mann-Whitney U test and Fisher test.

Results: Ninety-five percent of the participants presented epilepsy, 45% intellectual deficit and 25% autistic disorder. The sample also presented clinical manifestations of conduct disorder, anxiety disorder and avoidant personality. There was a significant relationship between intellectual deficit and the following variables: number of medications used for epilepsy (p=0.002), use of benzodiazepine in the treatment of epilepsy (p=0.005) and autism (p=0.008).

Conclusion: The sample presented a high prevalence of epilepsy, cognitive deficit and psychiatric disorders, as demonstrated by other studies in similar population. Intellectual deficit was associated with a higher number of drugs used to treat epilepsy and autism.

Author Biographies

Mariana Richartz Schwind, Universidade Federal do Paraná

Psicóloga pela UFPR. Acadêmica em Medicina pela UFPR. Pesquisadora voluntária do Centro de Neuropediatria do Hospital de Clínicas da UFPR.

Laís Faria Masulk Cardozo, Universidade Federal do Paraná

Psicóloga, Mestranda em Saúde da Infância e Adolescência pela UFPR

Sergio Antonio Antoniuk, Universidade Federal do Paraná

Centro de Neuropediatria do Hospital de Clínicas da Universidade Federal do Paraná (UFPR), Prof. Adjunto do Departamento de Pediatria da UFPR

Ana Paula Almeida de Pereira, Universidade Federal do Paraná

Prof. Adjunto do Departamento de Psicologia da Universidade Federal do Paraná

Daniele Fajardo Nascimento, Universidade Federal do Paraná

Mestre em Saúde da Infância e Adolescência pela UFPR

Daiane Alex Seccon Azevedo, Universidade Federal do Paraná

Graduanda em Psicologia pela UFPR

Nayana Miranda de Freitas Falcão, Universidade Federal do Paraná

Mestranda em Saúde da Infância e Adolescência pela UFPR

Isac Bruck, Universidade Federal do Paraná

Médico neuropediatra, Centro de Neuropediatria da Universidade Federal do Paraná

 

Published

2017-06-30

Issue

Section

Artigos Originais